» Articles » PMID: 6854445

Early-treated Phenylketonuria: Neuropsychologic Consequences

Overview
Journal J Pediatr
Specialty Pediatrics
Date 1983 Jun 1
PMID 6854445
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Twenty-seven children with phenylketonuria who had undergone dietary restriction of phenylalanine since infancy were administered a battery of neuropsychologic tests in childhood. Children without PKU were also assessed. Discriminant function analysis of the neuropsychologic measures resulted in correct diagnostic classification for 94% of the total sample. Measured intelligence, school achievement, concept formation, and tactile-motor problem solving were the most powerful discriminators. In general, motor speed and coordination were not significantly different in patients compared with nonpatients. Serum phenylalanine concentration on the day of neuropsychologic testing was negatively correlated with performance. Correlation coefficients between infant serum phenylalanine concentrations and later neuropsychologic performance did not reach statistical significance. We suggest that concurrent serum phenylalanine concentrations affect neuropsychologic performance and that therefore the practice of terminating dietary restriction requires further scrutiny.

Citing Articles

Executive function impairment in early-treated PKU subjects with normal mental development.

Leuzzi V, Pansini M, Sechi E, Chiarotti F, Carducci C, Levi G J Inherit Metab Dis. 2004; 27(2):115-25.

PMID: 15159642 DOI: 10.1023/B:BOLI.0000028781.94251.1f.


Behaviour and school achievement in patients with early and continuously treated phenylketonuria.

Stemerdink B, Kalverboer A, van der Meere J, van der Molen M, Huisman J, de Jong L J Inherit Metab Dis. 2000; 23(6):548-62.

PMID: 11032330 DOI: 10.1023/a:1005669610722.


Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.

Smith M, Hanley W, Clarke J, Klim P, Schoonheyt W, Austin V Arch Dis Child. 1998; 78(2):116-21.

PMID: 9579151 PMC: 1717450. DOI: 10.1136/adc.78.2.116.


Adult psychosocial outcome in early-treated phenylketonuria.

Ris M, Weber A, HUNT M, BERRY H, Williams S, Leslie N J Inherit Metab Dis. 1997; 20(4):499-508.

PMID: 9266385 DOI: 10.1023/a:1005389110739.


Haemostatic variables in phenylketonuric children under dietary treatment.

Schulpis K, Platokouki H, Papakonstantinou E, Adamtziki E, Bargeliotis A, Aronis S J Inherit Metab Dis. 1996; 19(5):603-9.

PMID: 8892015 DOI: 10.1007/BF01799833.